**media[1233819]** Combining Cellid's Technological Expertise with Megane Top's Product Development and Sales Capabilities to Bring AR Glasses to Market

SHANGHAI, China, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. ('Fangzhou” or the 'Company”) (HKEX: 06086), a leading provider of AI‑driven Internet healthcare solutions, has released its 2026 interim report, highlighting continued progress in its 'AI + Chronic Disease Services” strategy as the Company advances its positioning as a full-lifecycle personal health service partner.